GW&K Investment Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-287,865
Closed -$368K – 502
2022
Q3
$368K Sell
287,865
-278,610
-49% -$607K ﹤0.01% 327
2022
Q2
$1.39M Buy
+566,475
New +$2.69M 0.02% 321

Other funds holding RNLX

GW&K Investment Management's RNLX Position: Q4 2022 in Review

GW&K Investment Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2022, closing a stake of 287,865 shares — an estimated $368K sold.

GW&K Investment Management first reported a position in RNLX in Q2 2022 and held it in 2 quarters. The position peaked at $1.39M in Q2 2022. 22 funds tracked by Wall St. Rank hold RNLX as of Q4 2022.

  • GW&K Investment Management reported no remaining Renalytix plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • GW&K Investment Management sold 287,865 Renalytix plc American Depositary Shares shares in Q4 2022, an estimated $368K.
  • GW&K Investment Management first reported a position in Renalytix plc American Depositary Shares in Q2 2022 and held it in 2 quarters.
  • GW&K Investment Management's Renalytix plc American Depositary Shares position peaked at $1.39M in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2022.

Based on GW&K Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.